МЕТАБОЛИЧЕСКИЕ ЭФФЕКТЫ ПРОЛОНГИРОВАННОГО АНТАГОНИСТА КАЛЬЦИЯ - АЛТИАЗЕМА-РР У БОЛЬНЫХ С МЯГКОЙ АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ

Antihypertensive efficacy and metabolic influence of long-acting calcium channel blocker – altiazem RR (diltiazem) was studied in 18 mild hypertensive patients with dislipoproteinemias. It was established that the daily use of 180 mg of49 the drug led to the effective control of blood pressure in majority of pts.The drug provided 24-hour control of blood pressure and induced mild decrease of pulse rate. Moreover, it appeared to be metabolicaly neutral : it did not affect lipid prоfile and blood glucose level. We conclude that altiazem RR is a modern drug of choice in hypertensive pts with accompaning metabolic disorders.